Skip to main content
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. — Investor Relations & Filings

Ticker · SLGL ISIN · IL0011417206 LEI · 5493003J2SQF7YM0BK11 US Manufacturing
Open in API
Filings indexed 305 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IL Israel
Listing US SLGL

About Sol-Gel Technologies Ltd.

http://www.sol-gel.com

Sol-Gel Technologies Ltd. is a dermatology company that develops and commercializes topical treatments for skin conditions. The company leverages a proprietary, silica-based microencapsulation technology to stabilize active ingredients and enable controlled drug delivery. Its portfolio includes commercialized products for acne vulgaris and rosacea. The development pipeline focuses on addressing unmet needs in rare dermatological diseases, with a lead candidate, patidegib gel, for the prevention of new basal cell carcinoma lesions in patients with Gorlin syndrome. Other therapeutic areas of interest include pachyonychia congenita and hyperkeratosis-related indications. The company's strategy involves identifying and developing promising dermatological assets to provide innovative formulations for patients.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 90% confidence The document is a Form 6-K, a current report of a foreign private issuer filed with the SEC, announcing the attached press release for quarterly financial results. It does not itself contain substantive financial statements but serves as a regulatory filing to disclose the issuance of the press release. Under the provided taxonomy, this falls under Regulatory Filings (RNS) as a miscellaneous SEC filing that does not fit other specific categories.
2026-05-28 English
6-K - Sol-Gel Technologies Ltd. (0001684693) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Sol-Gel Technologies Ltd., reporting an underwriting agreement for a registered direct offering of ordinary shares. It includes details about the offering, the underwriting agreement, and related exhibits such as the underwriting agreement itself, legal opinion, and a press release. The document is 4604 characters long, which is relatively short and primarily serves as an announcement of a financing event rather than a full financial report. The content focuses on capital raising activities and the issuance of shares. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-03-24 English
424B5 - Sol-Gel Technologies Ltd. (0001684693) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying prospectus filed pursuant to Rule 424(b)(5) under the Securities Act, related to an offering of ordinary shares. It includes detailed information about the offering price, underwriting discounts, use of proceeds, risk factors, and company background. The document is a formal offering document used to raise capital through a share issuance. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the share offering, not merely an announcement or a brief summary. Therefore, it is not a Report Publication Announcement or Regulatory Filing. It is not an Annual Report, Earnings Release, or any other category related to financial results or governance. Hence, the correct classification is CAP with high confidence.
2026-03-24 English
EFFECT - Sol-Gel Technologies Ltd. (0001684693) (Filer)
Regulatory Filings
2026-03-24 English
SCHEDULE 13G/A - Sol-Gel Technologies Ltd. (0001684693) (Subject)
Major Shareholding Notification
2026-03-23 English
POS AM - Sol-Gel Technologies Ltd. (0001684693) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 4 to a Registration Statement on Form F-1, converted to Form F-3, filed with the SEC. It references registration of securities for resale by selling shareholders, details about the securities, and legal disclaimers. The document is a registration statement amendment related to securities offering and resale, not a financial report, earnings release, or management discussion. It is a formal SEC filing related to capital raising and securities registration. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is substantial (15,000 characters), and it contains detailed offering and registration information, not just an announcement or certification. Therefore, the best classification is CAP with high confidence.
2026-03-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.